Nasdaq
$2.33▲ 2.19%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $466.3MShares out 200M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 10.13Pre-market26.10.13 22:268-KKey event#●●●#●●●
SS Innovations International, Inc.Bullish
SS Innovations submitted its response to the U.S. Food and Drug Administration's (FDA) request for additional information (AINN) on October 5, 2026. The response includes final data from clinical and human factors validation studies for the SSi Mantra surgical robotic system to support its 510(k) submission. The company anticipates the FDA will complete its review of the submission in the first quarter of 2027.…more
$2.33+2.19%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.13Pre-market26.10.13 19:058-KKey event
SS Innovations International, Inc.
SS Innovations International has entered into a securities purchase agreement with an institutional investor to issue a secured convertible promissory note with a principal amount of $21,025,000, raising $20,000,000 in gross proceeds. The note matures in 36 months, bears an annual interest rate of 8.75%, and is secured by the company's intellectual property and assets. The investor has the right to convert the outstanding balance into common shares at a conversion price equal to 95% of the market price.…more
$2.33+2.19%vs prev closeView filingShare - 10.9After-hours26.10.10 06:104Ownership
SS Innovations International, Inc.
Insider Sudhir Srivastava of SS Innovations International, Inc. filed a Form 4 statement regarding changes in beneficial ownership of securities on October 9, 2026. This filing serves as an official record of the insider's equity transaction.…more
$2.33+2.19%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.13Pre-market26.10.13 21:30#●●●#●●●
SS Innovations Submits Additional Data for FDA SSi Mantra Approval
SS Innovations has submitted its response to the FDA's request for additional information regarding the 510(k) clearance for its SSi Mantra surgical robotic system. The company expects the FDA to complete its review of the submission in the first quarter of 2027.…more
$2.33+2.19%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.10Pre-market26.09.10 21:30
●●●●●●●● ●●●●● ●●●●●●
SS Innovations reported significant growth in the global installation and utilization of its 'SSi Mantra' surgical robotic system. The company also provided a timeline for upcoming U.S. FDA and EU regulatory approvals to support its international expansion.…more
$2.33+2.19%vs prev close - 8.26After-hours26.08.27 05:42
●●●●●●●● ●●●●● ●●●●●●
Sarah Romano has stepped down as the Chief Financial Officer of SS Innovations, effective August 21, 2026. The company stated that her departure was not due to any disagreements regarding financial reporting or accounting practices.…more
$2.33+2.19%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report